Linda A. DeGraffenried
Division of Medical Oncology
University of Texas Health Science Center at San Antonio
San Antonio
TX 78229
USA
Name/email consistency: high
- NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. deGraffenried, L.A., Chandrasekar, B., Friedrichs, W.E., Donzis, E., Silva, J., Hidalgo, M., Freeman, J.W., Weiss, G.R. Ann. Oncol. (2004)
- Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried, L.A., Friedrichs, W.E., Russell, D.H., Donzis, E.J., Middleton, A.K., Silva, J.M., Roth, R.A., Hidalgo, M. Clin. Cancer Res. (2004)
- Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. DeGraffenried, L.A., Friedrichs, W.E., Fulcher, L., Fernandes, G., Silva, J.M., Peralba, J.M., Hidalgo, M. Ann. Oncol. (2003)